CA2424222A1 - Inhibiteurs de la prenyl-proteine transferase - Google Patents
Inhibiteurs de la prenyl-proteine transferase Download PDFInfo
- Publication number
- CA2424222A1 CA2424222A1 CA002424222A CA2424222A CA2424222A1 CA 2424222 A1 CA2424222 A1 CA 2424222A1 CA 002424222 A CA002424222 A CA 002424222A CA 2424222 A CA2424222 A CA 2424222A CA 2424222 A1 CA2424222 A1 CA 2424222A1
- Authority
- CA
- Canada
- Prior art keywords
- unsubstituted
- substituted
- indol
- acetamide
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention se rapporte à des composés bicycliques fondus qui inhibent la prényl-protéine transférase et la prénylation de la protéine oncogène Ras. Cette invention concerne également des compositions chimiothérapeutiques contenant les composés de ladite invention ainsi que des procédés pour inhiber la prényl-protéine transférase et la prénylation de la protéine oncogène Ras.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23724100P | 2000-10-02 | 2000-10-02 | |
US60/237,241 | 2000-10-02 | ||
PCT/US2001/042389 WO2002028831A1 (fr) | 2000-10-02 | 2001-09-28 | Inhibiteurs de la prenyl-proteine transferase |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2424222A1 true CA2424222A1 (fr) | 2002-04-11 |
Family
ID=22892897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002424222A Abandoned CA2424222A1 (fr) | 2000-10-02 | 2001-09-28 | Inhibiteurs de la prenyl-proteine transferase |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1324985A4 (fr) |
JP (1) | JP2004510762A (fr) |
AU (1) | AU2002211828A1 (fr) |
CA (1) | CA2424222A1 (fr) |
WO (1) | WO2002028831A1 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4259877B2 (ja) | 2000-12-11 | 2009-04-30 | アムジエン・インコーポレーテツド | Cxcr3アンタゴニスト |
US6794379B2 (en) | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
GB0115109D0 (en) | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
EP1457205A4 (fr) * | 2001-11-30 | 2006-07-05 | Santen Pharmaceutical Co Ltd | Inhibiteur d'angiogenese |
CA2508290C (fr) | 2002-12-20 | 2017-02-28 | Ciba Specialty Chemicals Holding Inc. | Synthese d'amines et intermediaires pour cette synthese |
CA2562783A1 (fr) | 2004-04-26 | 2005-12-01 | Vanderbilt University | Derives d'acides indoleacetique et indenacetique comme agents therapeutiques a toxicite gastrointestinale reduite |
CA2569887A1 (fr) | 2004-06-09 | 2005-12-22 | Glaxo Group Limited | Derives de pyrrolopyridine |
US7271271B2 (en) | 2004-06-28 | 2007-09-18 | Amgen Sf, Llc | Imidazolo-related compounds, compositions and methods for their use |
CN101528222A (zh) | 2006-06-19 | 2009-09-09 | 范德比尔特大学 | 用于诊断性和治疗性靶向cox-2的方法和组合物 |
CL2007002617A1 (es) | 2006-09-11 | 2008-05-16 | Sanofi Aventis | Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto. |
AR072297A1 (es) | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
US8921533B2 (en) | 2011-07-25 | 2014-12-30 | Chromatin Technologies | Glycosylated valproic acid analogs and uses thereof |
US9346803B2 (en) | 2011-10-17 | 2016-05-24 | Vanderbilt University | Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
US11311519B2 (en) | 2014-05-01 | 2022-04-26 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
DK3137078T3 (da) * | 2014-05-01 | 2019-06-11 | Eiger Biopharmaceuticals Inc | Behandling af hepatitis delta-virusinfektion |
US10076512B2 (en) | 2014-05-01 | 2018-09-18 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
WO2016054807A1 (fr) * | 2014-10-10 | 2016-04-14 | Merck Sharp & Dohme Corp. | Inhibiteurs de la kinase trka, compositions en contenant et méthodes associées |
US9862698B2 (en) | 2014-12-16 | 2018-01-09 | Adt Pharmaceuticals, Inc. | Indenyl compounds, pharmaceutical compositions, and medical uses thereof |
US20160168108A1 (en) | 2014-12-16 | 2016-06-16 | Adt Pharmaceuticals, Inc. | Method of treating or preventing ras-mediated diseases |
KR20220147695A (ko) | 2015-04-21 | 2022-11-03 | 아이거 바이오파마슈티컬스 인코포레이티드 | 로나파르닙 및 리토나버를 포함하는 약제 조성물 |
EP3468545A4 (fr) | 2016-06-08 | 2020-07-22 | President and Fellows of Harvard College | Procédés et compositions pour réduire le dysfonctionnement tactile et l'anxiété associés au trouble du spectre de l'autisme, au syndrome de rett et au syndrome de l'x fragile |
US11186596B2 (en) | 2018-04-26 | 2021-11-30 | Adt Pharmaceuticals, Llc | Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses |
WO2019232046A1 (fr) | 2018-05-29 | 2019-12-05 | President And Fellows Of Harvard College | Compositions et méthodes pour réduire un dysfonctionnement tactile, l'anxiété et une déficience sociale |
US11618746B2 (en) | 2018-12-17 | 2023-04-04 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and methods of using same |
IL296035A (en) | 2020-03-06 | 2022-10-01 | Vertex Pharma | Treatment methods for apol-1 dependent focal segmental tuberous sclerosis |
AU2021286666A1 (en) * | 2020-06-12 | 2023-01-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and use of the same |
US11866446B2 (en) | 2020-08-26 | 2024-01-09 | Vertex Pharmaceuticals Incorporated | Inhibitors of APOL1 and methods of using same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3314964A (en) * | 1964-01-16 | 1967-04-18 | Warner Lambert Pharmaceutical | Trans indolomorphinans and process for their production |
US4656182A (en) * | 1983-12-06 | 1987-04-07 | Warner-Lambert Company | Substituted trans-1,2-diaminocyclohexyl amide compounds |
WO1992004321A1 (fr) * | 1990-09-10 | 1992-03-19 | Rhone-Poulenc Rorer International (Holdings) Inc. | Composes aryles bicycliques substitues presentant une activite selective antagoniste contre les leucotrienes b4 |
KR100362864B1 (ko) * | 1994-02-22 | 2003-04-16 | 메렐 파마슈티칼스 인크. | 에스트로겐관련신생물및질환의치료에유용한신규인돌유도체 |
AU3645697A (en) * | 1996-07-08 | 1998-02-02 | Du Pont Pharmaceuticals Company | Amidinoindoles, amidinoazoles, and analogs thereof as inhibitors of factor xa and of thrombin |
JP2001089448A (ja) * | 1999-09-24 | 2001-04-03 | Yamanouchi Pharmaceut Co Ltd | アミド誘導体 |
AU2001228681A1 (en) * | 2000-01-28 | 2001-08-07 | Melacure Therapeutics Ab | Novel aromatic amines and amides acting on the melanocortin receptors |
-
2001
- 2001-09-28 AU AU2002211828A patent/AU2002211828A1/en not_active Abandoned
- 2001-09-28 EP EP01979912A patent/EP1324985A4/fr not_active Withdrawn
- 2001-09-28 CA CA002424222A patent/CA2424222A1/fr not_active Abandoned
- 2001-09-28 WO PCT/US2001/042389 patent/WO2002028831A1/fr not_active Application Discontinuation
- 2001-09-28 JP JP2002532417A patent/JP2004510762A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1324985A1 (fr) | 2003-07-09 |
WO2002028831A1 (fr) | 2002-04-11 |
AU2002211828A1 (en) | 2002-04-15 |
EP1324985A4 (fr) | 2004-10-06 |
JP2004510762A (ja) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2424222A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
WO2001060369A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
US20020052380A1 (en) | Inhibitors of prenyl-protein transferase | |
US6284755B1 (en) | Inhibitors of prenyl-protein transferase | |
US20020010184A1 (en) | Inhibitors of prenyl-protein transferase | |
US6441017B1 (en) | Inhibitors of prenyl-protein transferase | |
WO2001017992A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
US6350755B1 (en) | Inhibitors of prenyl-protein transferase | |
US6410534B1 (en) | Inhibitors of prenyl-protein transferase | |
US6329376B1 (en) | Inhibitors of prenyl-protein transferase | |
WO2001045707A1 (fr) | Inhibiteurs de prenyl-proteine transferase | |
US6632818B2 (en) | Inhibitors of prenyl-protein transferase | |
CA2426684A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
US6316436B1 (en) | Inhibitors of prenyl-protein transferase | |
US6566385B2 (en) | Inhibitors of prenyl-protein transferase | |
AU762440B2 (en) | Inhibitors of prenyl-protein transferase | |
WO2002079147A2 (fr) | Inhibiteurs de la prenyl-proteine-transferase | |
US20020022633A1 (en) | Inhibitors of prenyl-protein transferase | |
US20040110764A1 (en) | Inhibitors of prenyl-protein transferase | |
WO2002078702A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
WO2001045704A1 (fr) | Inhibiteurs de la prenyl-proteine transferase | |
WO2002020015A1 (fr) | Inhibiteurs de prenyle-proteine transferase | |
US6380228B1 (en) | Inhibitors of prenyl-protein transferase | |
US6534506B2 (en) | Inhibitors of prenyl-protein transferase | |
CA2362494A1 (fr) | Inhibiteurs de prenyl-proteine transferases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |